Rakuten Investment Management Inc. purchased a new position in shares of AMETEK, Inc. (NYSE:AME – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 41,146 shares of the technology company’s stock, valued at approximately $10,319,000.
A number of other institutional investors have also modified their holdings of AME. BlackRock Inc. purchased a new stake in shares of AMETEK in the second quarter worth about $4,725,928,000. Wellington Management Group LLP grew its holdings in AMETEK by 7.0% during the second quarter. Wellington Management Group LLP now owns 2,994,077 shares of the technology company’s stock worth $724,387,000 after acquiring an additional 196,986 shares during the period. Flossbach Von Storch SE purchased a new position in AMETEK during the second quarter valued at approximately $662,352,000. Bank of New York Mellon Corp purchased a new position in AMETEK during the second quarter valued at approximately $624,725,000. Finally, Dimensional Fund Advisors LP lifted its holdings in AMETEK by 1.4% in the first quarter. Dimensional Fund Advisors LP now owns 2,075,229 shares of the technology company’s stock valued at $444,788,000 after acquiring an additional 29,001 shares during the period. Hedge funds and other institutional investors own 87.43% of the company’s stock.
AMETEK Price Performance
NYSE:AME opened at $222.59 on Friday. The company has a quick ratio of 0.76, a current ratio of 1.43 and a debt-to-equity ratio of 0.52. AMETEK, Inc. has a 52 week low of $188.47 and a 52 week high of $261.16. The stock’s 50-day moving average price is $243.19 and its 200-day moving average price is $234.54. The stock has a market capitalization of $51.04 billion, a PE ratio of 31.40, a price-to-earnings-growth ratio of 2.11 and a beta of 0.96.
Analyst Upgrades and Downgrades
Several research firms have commented on AME. Zacks Research upgraded AMETEK from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 6th. Vertical Research started coverage on shares of AMETEK in a research note on Tuesday, September 8th. They set a “buy” rating and a $255.00 price objective on the stock. DA Davidson set a $285.00 target price on shares of AMETEK in a report on Wednesday, October 7th. Rothschild & Co Redburn boosted their target price on shares of AMETEK from $265.00 to $275.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Finally, Mizuho lowered their price target on shares of AMETEK from $285.00 to $275.00 and set an “outperform” rating on the stock in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $278.06.
View Our Latest Stock Report on AME
AMETEK News Summary
Here are the key news stories impacting AMETEK this week:
- Positive Sentiment: AMETEK reported record third-quarter sales, with earnings beating estimates. Organic sales growth, a record backlog and margin expansion supported higher 2026 earnings and free-cash-flow guidance. Zacks Q3 earnings article
- Positive Sentiment: RBC raised its price target to $308 from $291 and maintained an Outperform rating. RBC price-target update
- Positive Sentiment: Citigroup lifted its target to $270 from $263, while keeping a Neutral rating. Citigroup rating
- Neutral Sentiment: Mizuho lowered its target to $275 from $285 but retained an Outperform rating, reflecting a more cautious target alongside continued optimism. Mizuho price-target update
- Negative Sentiment: AME fell sharply after the results, despite the earnings beat and raised outlook. The reaction suggests investors may have been expecting more or were taking profits; the cited coverage does not confirm a specific catalyst. Yahoo Finance analysis of AMETEK’s post-results decline
AMETEK Company Profile
AMETEK, Inc is a global manufacturer of industrial technology solutions. The company develops and produces advanced analytical, monitoring, testing, and measurement instruments, as well as engineered electromechanical products used in industrial, aerospace, defense, energy, medical, and other specialized markets.
AMETEK operates through two primary business groups: Electronic Instruments and Electromechanical. Its products include process and power monitoring systems, analytical instruments, automation and control technologies, aerospace and defense equipment, precision motion-control systems, motors, thermal-management solutions, engineered materials, and specialty metal products.
The company traces its roots to 1930 and has expanded through the development and acquisition of specialized technology businesses.
See Also
- Five stocks we like better than AMETEK
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.
